Cheryl Harth
Medical Oncology · Dallas, TXNPI 1407894413
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,225 of the $17,813 with a category attached, or 68.6%. 23 manufacturers reported payments, led by Novartis at 41.5% of the total.
Across 59 payments — averaging $301.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$7K
- Eisai Inc.$5K
- Seagen Inc.$2K
- Merck$459
- Bayer$267
- Tesaro, Inc.$238
- plus $2K from 17 others
Across 54 payments — averaging $3837.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$118K
- Amgen$70K
- Janssen Research & Development, LLC$20K
What the payments were for
- Consulting fees$12,22569%
- Travel & lodging$1,90211%
- Food & beverage$3,61120%
- Education$750%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 8 | $7,401 |
| Eisai Inc. | 11 | $5,202 |
| Seagen Inc. | 2 | $2,155 |
| Merck | 4 | $459 |
| Bayer | 3 | $267 |
| Tesaro, Inc. | 2 | $238 |
| Johnson & Johnson | 2 | $229 |
| AbbVie | 3 | $227 |
| Pfizer | 3 | $142 |
| Astellas Pharma US Inc | 3 | $135 |
| AstraZeneca | 1 | $125 |
| Daiichi Sankyo Inc. | 1 | $122 |
| Puma Biotechnology, Inc. | 1 | $121 |
| Clovis Oncology, Inc. | 1 | $118 |
| Incyte Corporation | 1 | $116 |
| Gilead | 1 | $116 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $113 |
| Genentech, Inc. | 1 | $110 |
| Heron Therapeutics, Inc. | 1 | $110 |
| Jazz Pharmaceuticals Inc. | 1 | $87 |
| Siemens Medical Solutions USA, Inc. | 5 | $75 |
| Amgen | 1 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $68 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,813 in reported general payments places this provider in the 65th percentile of 495 medical oncology providers in Texas.
Other medical oncology in Dallas
- Moshe LevyDallas$5.1M
- Andrew WhiteleyDallas$1.7M
- Eric NadlerDallas$1.6M
- Joyce O'ShaughnessyDallas$1.3M
- Ronan KellyDallas$1.1M
- Thomas HutsonDallas$944K
- Heather McArthurDallas$314K
- Tian ZhangDallas$286K
- Micah BurchDallas$221K
- David JohnsonDallas$212K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.